Search
for
Sort by
Research 30 of 300
- Alopecia Due to Psychotropic Medications
- Psychotropic Medication and Drug-Related Alopecia
- Psychotropic Medications and the Skin
- Patterns of psychotropic medication prescribing and potential drug-hormone interactions among transgender and gender-diverse adults within 2 years of hormone therapy
- Dermatologic Side Effects of Psychotropic Medications
- Adverse cutaneous effects of psychotropic medications
- Culprits of Medication-Induced Telogen Effluvium, Part 1
- Adverse effects of common medications on male fertility
- Update on psychodermatological disorders
- Bipolar Patients and Bullous Pemphigoid after Risperidone Long-Acting Injectable: A Case Report and a Review of the Literature
- Quetiapine Induced Hair Loss in an Adolescent Case
- Alopecia areata associated with haloperidol decanoate long-acting injection
- Hair loss due to aripipirazole use: a case report
- Investigating the effectiveness of treatments used in trichotillomania
- Drugs and Hair Loss
- Alopecia and drugs
- Psychoactive drugs and skin
- [Drug-induced alopecia: review of the literature].
- The role of biotransformation processes in mediating interactions between psychotropic drugs and natural products
- Cutaneous drug reactions
- Alleviation of alopecia after switching from escitalopram to duloxetine: a case report
- Psychological interventions in the management of common skin conditions
- Severe hair loss associated with psyc hotropic drugs in psychiatric inpatients—Data from an observational pharmacovigilance program in German-speaking countries
- Effets indésirables des médicaments sur la fertilité masculine : étude dans la base de données Vigibase
- A Review of the Role of Psychiatrists and Pediatricians in Outpatient Treatment of Adolescents with Anorexia and Bulimia Nervosa
- Table of Contents
- Psychosis as a late manifestation of Sheehan’s syndrome
- Treatment of pseudofolliculitis in trichotillomania improves outcome
- To σύνδρομο της δερματίτιδας από λείξη των άκρων στο σκύλο
- Abstracts from the 17th Congress of the European Society for Dermatology and Psychiatry